Table 4 Patient characteristics of the test group and the validation group. The p-values were obtained from the Chi-square test
From: A new score predicting the survival of patients with spinal cord compression from myeloma
Test group | Validation group | p-value | |
|---|---|---|---|
n patients (%) | n patients (%) | ||
Age | |||
≤ 63 years | 57 (53) | 54 (50) | |
≥ 64 years | 51 (47) | 54 (50) | 0.84 |
Gender | |||
Female | 38 (35) | 42 (39) | |
Male | 70 (65) | 66 (71) | 0.81 |
ECOG Performance status | |||
1-2 | 75 (69) | 70 (65) | |
3-4 | 33 (31) | 38 (35) | 0.73 |
Number of involved vertebrae | |||
1-2 | 48 (44) | 50 (46) | |
≥ 3 | 60 (56) | 58 (54) | 0.91 |
Ambulatory status prior to radiotherapy | |||
Not Ambulatory | 27 (25) | 32 (30) | |
Ambulatory before RT | 81 (75) | 76 (70) | 0.75 |
Other bone lesions | |||
No | 45 (42) | 43 (40) | |
Yes | 63 (58) | 65 (60) | 0.92 |
Extraosseous lesions | |||
No | 105 (97) | 102 (94) | |
Yes | 3 (3) | 6 (6) | 0.89 |
Interval from cancer diagnosis to radiotherapy of MSCC | |||
≤ 15 months | 58 (54) | 59 (55) | |
> 15 months | 50 (46) | 49 (45) | 0.95 |
Time developing motor deficits | |||
1-14 days | 46 (43) | 50 (46) | |
> 14 days | 62 (57) | 58 (54) | 0.78 |
Radiation regimen | |||
Short-course radiotherapy | 37 (34) | 38 (35) | |
Longer-course radiotherapy | 71 (66) | 70 (65) | 0.96 |